Califf’s passions, RWE in China & LSP rising

BioCentury’s latest podcast examines the priorities of FDA’s likely next commissioner

Rob Califf’s prolific writings on topics he would face if he confirmed as FDA’s next commissioner provide insights into the passions that would drive his priorities in the role. On the latest BioCentury This Week podcast, BioCentury’s editors examine Califf’s commentaries and peer-reviewed papers for clues to what a second tenure by FDA might look like. The team also discusses the challenges and opportunities for real-world evidence in China, looks at what’s next for European life sciences VC LSP now that it is part of a large PE firm and highlights this week’s selection of emerging biotechs. The editors preview the BioCentury-BayHelix China Healthcare Summit, which is now under way in Shanghai and online.